Page 225 - Hospital Authority Convention 2018
P. 225

Service Enhancement Presentations



                F8.4      Young HA Investigators Session                                   14:30  Room 421

               Reduction of Radiation and Intravenous Contrast Doses in Triphasic Contrast Computed Tomography
               Abdominal Aortogram
               Mo CKM, Cheng JHM, Lee ASL, Lam KM, Leung BST, Chu CY, Tam CW, Kan WK
               Department of Radiology, Pamela Youde Nethersole Eastern Hospital, Hong Kong                        HOSPITAL AUTHORITY CONVENTION 2018

               Introduction
               Prolonged nature of imaging surveillance by Computed Tomography abdominal aortogram (CTAA) with triphasic protocols
               impose substantial radiation exposure and contrast doses to post-EVAR patients, who are at higher risk for renal impairment.

               Objectives
               To  reduce  both  radiation  and  intravenous  contrast  doses  of  CTAA  via  implementation  of  new  imaging  protocol,  while
               maintaining comparable diagnostic quality.

               Methodology
               A three-phase project from 1 April 2015 to 30 September 2017 was conducted, including consecutive patients who
               underwent triphasic CTAA in our department. In the second and third phases, urgent examinations were excluded. To
               benchmark baseline radiation doses, data from first phase (1 April 2015  – 31 December 2015) were retrospectively analysed.
               A new low-contrast low-kV protocol was implemented in second phase (1 March 2016  – 30 November 2016), in which tube
               voltage was reduced from 120kV to 100kV, and intravenous contrast (Omnipaque 350mg/ml) was reduced from 80ml to 60ml.
               Further refinement of protocol was performed in the third phase (1 January 2017  – 30 September 2017), tube current was
               adjusted to a low-dose protocol (SureExp 3D® Low Dose) in plain and arterial phases, and remained unchanged in delayed
               phase (SureExp 3D® Standard). Patient demographics and radiation doses in terms of dose-length products (DLPs, mGycm)
               of each case were collected. To ensure comparable diagnostic confidence, both quantitative and qualitative image quality
               assessment were performed. Quantitative parameters included aortic enhancement, contrast attenuation gradient, image
               noise and contrast-to-noise ratio. For qualitative parameters, visual assessment analysis was performed by two radiologists
               based on grading scale (noise 1-3, artefact 1-3, diagnostic quality 1-5).

               Results
               Mean DLP from baseline assessment of 55 patients (mean 78.5 years) was 2102.5mGycm. In second phase, all 35 patients
               (mean 79.5 years) received 25% reduction in contrast volume. Mean DLP was 1866.3mGycm, equivalent to 11.2% reduction.
               For image quality, all quantitative and qualitative parameters showed no significant differences. In third phase, 35 patients
               (mean 76.4 years) were included. Mean DLP was further reduced to 1721.0mGycm, equivalent to further reduction by 7.8%
               and overall reduction by 18.1%. Mild increase image noise in arterial phase from 12.8HU to 16.7HU was noted. However, there
               was no significant difference in qualitative image noise assessment, as well as other quantitative and qualitative parameters
               of image quality.                                                                                   Tuesday, 8 May 2018







































                                                                                                                  223
   220   221   222   223   224   225   226   227   228   229   230